Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Real-World Treatment Patterns of Bruton Tyrosine Kinase Inhibitors Among Patients With Mantle Cell Lymphoma

Bijal Shah, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, discusses his study which assessed patient characteristics, treatment patterns and associated outcomes in real-world BTKi-treated patients with MCL.

This study was presented at the 2022 ASCO Annual Meeting. 

Advertisement

Advertisement

Advertisement